Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -386.90K | -701.60K | -1.38M | -907.90K | -265.60K |
| Total Depreciation and Amortization | 48.00K | 64.40K | 78.10K | 99.10K | 102.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00 | 0.00 | 0.00 | 0.00 | -- |
| Change in Net Operating Assets | -271.50K | -906.80K | -2.10M | -33.00K | 133.70K |
| Cash from Operations | -610.30K | -1.54M | -3.41M | -841.80K | -29.70K |
| Capital Expenditure | -1.80K | -20.10K | -2.20K | 10.70K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.80K | -20.10K | -2.20K | 10.70K | -20.00K |
| Total Debt Issued | 458.70K | 180.70K | 263.00K | 425.10K | 409.30K |
| Total Debt Repaid | -11.20K | -837.60K | -- | -- | -- |
| Issuance of Common Stock | -- | 5.49M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -5.60M | 5.64M | -16.80K | -16.80K |
| Cash from Financing | 447.50K | -765.50K | 5.90M | 408.30K | 392.50K |
| Foreign Exchange rate Adjustments | -82.70K | 49.40K | 39.70K | 433.10K | -303.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -247.40K | -2.28M | 2.53M | 10.20K | 39.00K |